Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling

After our discovery that H-c[Cys-Phe-Phe-DNal-Lys-Thr-Phe-Cys]-OH (ODN-8) had high affinity and marginal selectivity for human sst(3) (part 2 of this series: Erchegyi et al. J. Med. Chem., preceding paper in this issue)(11) and that H-c[Cys-Phe-Phe-DTrp-Lys-Thr-Phe-Cys]-OH (ODT-8, 3) had high affini...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 2003-12, Vol.46 (26), p.5597-5605
Hauptverfasser: Erchegyi, Judit, Waser, Beatrice, Schaer, Jean-Claude, Cescato, Renzo, Brazeau, Jean François, Rivier, Jean, Reubi, Jean Claude
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 5605
container_issue 26
container_start_page 5597
container_title Journal of medicinal chemistry
container_volume 46
creator Erchegyi, Judit
Waser, Beatrice
Schaer, Jean-Claude
Cescato, Renzo
Brazeau, Jean François
Rivier, Jean
Reubi, Jean Claude
description After our discovery that H-c[Cys-Phe-Phe-DNal-Lys-Thr-Phe-Cys]-OH (ODN-8) had high affinity and marginal selectivity for human sst(3) (part 2 of this series: Erchegyi et al. J. Med. Chem., preceding paper in this issue)(11) and that H-c[Cys-Phe-Phe-DTrp-Lys-Thr-Phe-Cys]-OH (ODT-8, 3) had high affinity and marginal selectivity for human sst(4), that H-c[Cys-Phe-Tyr-D-threo-beta-Me2Nal-Lys-Thr-Phe-Cys]-OH had high affinity for all sst's except for sst(1), and that H-c[Cys-Phe-Tyr-L-threo-beta-Me2Nal-Lys-Thr-Phe-Cys]-OH had high affinity for sst(4) (IC(50) = 2.1 nM), with more than 50-fold selectivity toward the other receptors (parts 1 and 2 of this series: Rivier et al. and Erchegyi et al. J. Med. Chem., preceding papers in this issue), we found H-c[Cys-Phe-Phe-Trp-Lys-Thr-Phe-Cys]-OH (OLT-8, 2), H-c[Cys-Phe-Phe-L-threo-beta-MeTrp-Lys-Thr-Phe-Cys]-OH (4) and H-c[Cys-Phe-Phe-D-threo-beta-MeTrp-Lys-Thr-Phe-Cys]-OH (5) to have very high affinity for sst(4) (IC(50) = 0.7, 1.8, and 4.0 nM, respectively) and 5- to 10-fold selectivity versus the other sst's. From earlier work, we concluded that an l-amino acid at position 8 and a tyrosine or 4-aminophenylalanine substitution at position 7 may lead to high sst(4) selectivity. In fact, [Tyr(7)]-2 (6) and [Tyr(7)]-3 (7) show ca. 5-fold selectivity for sst(4), and [Aph(7)]-2 (8) and [Aph(7)]-3 (9) have high sst(4) affinity (IC(50) = 1.2 and 0.88 nM, respectively) and selectivity, suggesting that indeed an l-residue at position 8 will direct selectivity toward sst(4). Unexpectedly, [Ala(7)]-2 (10) and [Ala(7)]-3 (11) have very high sst(4) affinity (IC(50) = 0.84 and 0.98 nM, respectively) and selectivity (>600- and 200-fold, respectively). The combination of Tyr(2) and dTrp(8) in analogues 14 and 22 did not affect the affinity of the analogues for sst(4) (IC(50) = 1.2 and 1.1 nM, respectively) but resulted in loss of selectivity, whereas the combination of Tyr(2) and LTrp(8) in H-Tyr-c[Cys-Phe-Aph-Trp-Lys-Thr-Phe-Cys]-OH (13) and H-Tyr-c[Cys-Phe-Ala-Trp-Lys-Thr-Phe-Cys]-OH(19) retained high affinity (IC(50) = 1.9 and 1.98 nM, respectively) and sst(4) selectivity (>50 and >250, respectively). Interestingly, the same substitutions at positions 2 and 7, with l-threo-beta-MeTrp at position 8, yielded a much less selective analogue (20). Carbamoylation of the N-terminus of most of these analogues resulted in slightly improved affinity, selectivity, or both. Other amino acid substitutions in this series, such as those with A
doi_str_mv 10.1021/jm030245x
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_71455867</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71455867</sourcerecordid><originalsourceid>FETCH-LOGICAL-p139t-cf18f28c911bf6ab6b2fb556390e9931b6beaa7064a9a25e8df1b0f538278503</originalsourceid><addsrcrecordid>eNo1kE1LAzEURbNQbK0u_AOSlbSLqfmYZGaWpVgtFAXtzsXwMn0pKZlJnaRF_70F6-rC5XC4XELuOJtyJvjjrmWSiVx9X5AhY0JkQgs5INcx7hhjkgt5RQY817oQPB-Sz9dwRE9jTON8kkX02CR3RBpDCynEBMl1dPzxvlxMKGxD52KKUyqndNaBD9sDRgotdmA80hRoDxsXPBj0rtvekEsLPuLtOUdkvXhaz1-y1dvzcj5bZXsuq5Q1lpdWlE3FubEajDbCGqW0rBhWleSnAgEKpnOoQCgsN5YbZpUsRVEqJkfk4U-778PXaVCqWxcb9B46DIdYFzxXqtTFCbw_gwfT4qbe966F_qf-f0P-ArjLXfs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71455867</pqid></control><display><type>article</type><title>Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling</title><source>MEDLINE</source><source>American Chemical Society Journals</source><creator>Erchegyi, Judit ; Waser, Beatrice ; Schaer, Jean-Claude ; Cescato, Renzo ; Brazeau, Jean François ; Rivier, Jean ; Reubi, Jean Claude</creator><creatorcontrib>Erchegyi, Judit ; Waser, Beatrice ; Schaer, Jean-Claude ; Cescato, Renzo ; Brazeau, Jean François ; Rivier, Jean ; Reubi, Jean Claude</creatorcontrib><description>After our discovery that H-c[Cys-Phe-Phe-DNal-Lys-Thr-Phe-Cys]-OH (ODN-8) had high affinity and marginal selectivity for human sst(3) (part 2 of this series: Erchegyi et al. J. Med. Chem., preceding paper in this issue)(11) and that H-c[Cys-Phe-Phe-DTrp-Lys-Thr-Phe-Cys]-OH (ODT-8, 3) had high affinity and marginal selectivity for human sst(4), that H-c[Cys-Phe-Tyr-D-threo-beta-Me2Nal-Lys-Thr-Phe-Cys]-OH had high affinity for all sst's except for sst(1), and that H-c[Cys-Phe-Tyr-L-threo-beta-Me2Nal-Lys-Thr-Phe-Cys]-OH had high affinity for sst(4) (IC(50) = 2.1 nM), with more than 50-fold selectivity toward the other receptors (parts 1 and 2 of this series: Rivier et al. and Erchegyi et al. J. Med. Chem., preceding papers in this issue), we found H-c[Cys-Phe-Phe-Trp-Lys-Thr-Phe-Cys]-OH (OLT-8, 2), H-c[Cys-Phe-Phe-L-threo-beta-MeTrp-Lys-Thr-Phe-Cys]-OH (4) and H-c[Cys-Phe-Phe-D-threo-beta-MeTrp-Lys-Thr-Phe-Cys]-OH (5) to have very high affinity for sst(4) (IC(50) = 0.7, 1.8, and 4.0 nM, respectively) and 5- to 10-fold selectivity versus the other sst's. From earlier work, we concluded that an l-amino acid at position 8 and a tyrosine or 4-aminophenylalanine substitution at position 7 may lead to high sst(4) selectivity. In fact, [Tyr(7)]-2 (6) and [Tyr(7)]-3 (7) show ca. 5-fold selectivity for sst(4), and [Aph(7)]-2 (8) and [Aph(7)]-3 (9) have high sst(4) affinity (IC(50) = 1.2 and 0.88 nM, respectively) and selectivity, suggesting that indeed an l-residue at position 8 will direct selectivity toward sst(4). Unexpectedly, [Ala(7)]-2 (10) and [Ala(7)]-3 (11) have very high sst(4) affinity (IC(50) = 0.84 and 0.98 nM, respectively) and selectivity (&gt;600- and 200-fold, respectively). The combination of Tyr(2) and dTrp(8) in analogues 14 and 22 did not affect the affinity of the analogues for sst(4) (IC(50) = 1.2 and 1.1 nM, respectively) but resulted in loss of selectivity, whereas the combination of Tyr(2) and LTrp(8) in H-Tyr-c[Cys-Phe-Aph-Trp-Lys-Thr-Phe-Cys]-OH (13) and H-Tyr-c[Cys-Phe-Ala-Trp-Lys-Thr-Phe-Cys]-OH(19) retained high affinity (IC(50) = 1.9 and 1.98 nM, respectively) and sst(4) selectivity (&gt;50 and &gt;250, respectively). Interestingly, the same substitutions at positions 2 and 7, with l-threo-beta-MeTrp at position 8, yielded a much less selective analogue (20). Carbamoylation of the N-terminus of most of these analogues resulted in slightly improved affinity, selectivity, or both. Other amino acid substitutions in this series, such as those with Amp (25, 26), Orn (27), or IAmp (29) at position 7, were also tolerated but with a 2- to 3-fold loss of affinity and concomitant loss of selectivity. Analogous peptides with a tyrosine at position 11 (31-36) were less selective than the corresponding peptides with a tyrosine at position 2. Several analogues in this series compared favorably with the non-peptide L-803,087 (37) in terms of affinity and selectivity. Analogues 8, 10, and 21 potently inhibited the forskolin-stimulated cAMP production in sst(4)-transfected cells, therefore acting as full agonists. Cold monoiodination of 19 yielded 21, with retention of high sst(4) selectivity and affinity (IC(50) = 3.5 nM). (125)Iodinated 19 selectively binds to sst(4)-transfected cells but not to sst(1-3)- or sst(5)-transfected cells. Binding in sst(4)-transfected cells was completely displaced by SRIF-28 or the sst(4)-selective L-803,087.</description><identifier>ISSN: 0022-2623</identifier><identifier>DOI: 10.1021/jm030245x</identifier><identifier>PMID: 14667214</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Autoradiography ; Binding, Competitive ; Cell Line ; Cricetinae ; Cyclic AMP - biosynthesis ; Humans ; Iodine Radioisotopes ; Isotope Labeling ; Ligands ; Membrane Proteins ; Oligopeptides - chemical synthesis ; Oligopeptides - chemistry ; Oligopeptides - pharmacology ; Peptides, Cyclic - chemical synthesis ; Peptides, Cyclic - chemistry ; Peptides, Cyclic - pharmacology ; Radioligand Assay ; Receptors, Somatostatin - agonists ; Receptors, Somatostatin - chemistry ; Somatostatin - analogs &amp; derivatives ; Somatostatin - chemical synthesis ; Somatostatin - chemistry ; Somatostatin - pharmacology ; Stereoisomerism ; Structure-Activity Relationship</subject><ispartof>Journal of medicinal chemistry, 2003-12, Vol.46 (26), p.5597-5605</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14667214$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Erchegyi, Judit</creatorcontrib><creatorcontrib>Waser, Beatrice</creatorcontrib><creatorcontrib>Schaer, Jean-Claude</creatorcontrib><creatorcontrib>Cescato, Renzo</creatorcontrib><creatorcontrib>Brazeau, Jean François</creatorcontrib><creatorcontrib>Rivier, Jean</creatorcontrib><creatorcontrib>Reubi, Jean Claude</creatorcontrib><title>Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling</title><title>Journal of medicinal chemistry</title><addtitle>J Med Chem</addtitle><description>After our discovery that H-c[Cys-Phe-Phe-DNal-Lys-Thr-Phe-Cys]-OH (ODN-8) had high affinity and marginal selectivity for human sst(3) (part 2 of this series: Erchegyi et al. J. Med. Chem., preceding paper in this issue)(11) and that H-c[Cys-Phe-Phe-DTrp-Lys-Thr-Phe-Cys]-OH (ODT-8, 3) had high affinity and marginal selectivity for human sst(4), that H-c[Cys-Phe-Tyr-D-threo-beta-Me2Nal-Lys-Thr-Phe-Cys]-OH had high affinity for all sst's except for sst(1), and that H-c[Cys-Phe-Tyr-L-threo-beta-Me2Nal-Lys-Thr-Phe-Cys]-OH had high affinity for sst(4) (IC(50) = 2.1 nM), with more than 50-fold selectivity toward the other receptors (parts 1 and 2 of this series: Rivier et al. and Erchegyi et al. J. Med. Chem., preceding papers in this issue), we found H-c[Cys-Phe-Phe-Trp-Lys-Thr-Phe-Cys]-OH (OLT-8, 2), H-c[Cys-Phe-Phe-L-threo-beta-MeTrp-Lys-Thr-Phe-Cys]-OH (4) and H-c[Cys-Phe-Phe-D-threo-beta-MeTrp-Lys-Thr-Phe-Cys]-OH (5) to have very high affinity for sst(4) (IC(50) = 0.7, 1.8, and 4.0 nM, respectively) and 5- to 10-fold selectivity versus the other sst's. From earlier work, we concluded that an l-amino acid at position 8 and a tyrosine or 4-aminophenylalanine substitution at position 7 may lead to high sst(4) selectivity. In fact, [Tyr(7)]-2 (6) and [Tyr(7)]-3 (7) show ca. 5-fold selectivity for sst(4), and [Aph(7)]-2 (8) and [Aph(7)]-3 (9) have high sst(4) affinity (IC(50) = 1.2 and 0.88 nM, respectively) and selectivity, suggesting that indeed an l-residue at position 8 will direct selectivity toward sst(4). Unexpectedly, [Ala(7)]-2 (10) and [Ala(7)]-3 (11) have very high sst(4) affinity (IC(50) = 0.84 and 0.98 nM, respectively) and selectivity (&gt;600- and 200-fold, respectively). The combination of Tyr(2) and dTrp(8) in analogues 14 and 22 did not affect the affinity of the analogues for sst(4) (IC(50) = 1.2 and 1.1 nM, respectively) but resulted in loss of selectivity, whereas the combination of Tyr(2) and LTrp(8) in H-Tyr-c[Cys-Phe-Aph-Trp-Lys-Thr-Phe-Cys]-OH (13) and H-Tyr-c[Cys-Phe-Ala-Trp-Lys-Thr-Phe-Cys]-OH(19) retained high affinity (IC(50) = 1.9 and 1.98 nM, respectively) and sst(4) selectivity (&gt;50 and &gt;250, respectively). Interestingly, the same substitutions at positions 2 and 7, with l-threo-beta-MeTrp at position 8, yielded a much less selective analogue (20). Carbamoylation of the N-terminus of most of these analogues resulted in slightly improved affinity, selectivity, or both. Other amino acid substitutions in this series, such as those with Amp (25, 26), Orn (27), or IAmp (29) at position 7, were also tolerated but with a 2- to 3-fold loss of affinity and concomitant loss of selectivity. Analogous peptides with a tyrosine at position 11 (31-36) were less selective than the corresponding peptides with a tyrosine at position 2. Several analogues in this series compared favorably with the non-peptide L-803,087 (37) in terms of affinity and selectivity. Analogues 8, 10, and 21 potently inhibited the forskolin-stimulated cAMP production in sst(4)-transfected cells, therefore acting as full agonists. Cold monoiodination of 19 yielded 21, with retention of high sst(4) selectivity and affinity (IC(50) = 3.5 nM). (125)Iodinated 19 selectively binds to sst(4)-transfected cells but not to sst(1-3)- or sst(5)-transfected cells. Binding in sst(4)-transfected cells was completely displaced by SRIF-28 or the sst(4)-selective L-803,087.</description><subject>Animals</subject><subject>Autoradiography</subject><subject>Binding, Competitive</subject><subject>Cell Line</subject><subject>Cricetinae</subject><subject>Cyclic AMP - biosynthesis</subject><subject>Humans</subject><subject>Iodine Radioisotopes</subject><subject>Isotope Labeling</subject><subject>Ligands</subject><subject>Membrane Proteins</subject><subject>Oligopeptides - chemical synthesis</subject><subject>Oligopeptides - chemistry</subject><subject>Oligopeptides - pharmacology</subject><subject>Peptides, Cyclic - chemical synthesis</subject><subject>Peptides, Cyclic - chemistry</subject><subject>Peptides, Cyclic - pharmacology</subject><subject>Radioligand Assay</subject><subject>Receptors, Somatostatin - agonists</subject><subject>Receptors, Somatostatin - chemistry</subject><subject>Somatostatin - analogs &amp; derivatives</subject><subject>Somatostatin - chemical synthesis</subject><subject>Somatostatin - chemistry</subject><subject>Somatostatin - pharmacology</subject><subject>Stereoisomerism</subject><subject>Structure-Activity Relationship</subject><issn>0022-2623</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kE1LAzEURbNQbK0u_AOSlbSLqfmYZGaWpVgtFAXtzsXwMn0pKZlJnaRF_70F6-rC5XC4XELuOJtyJvjjrmWSiVx9X5AhY0JkQgs5INcx7hhjkgt5RQY817oQPB-Sz9dwRE9jTON8kkX02CR3RBpDCynEBMl1dPzxvlxMKGxD52KKUyqndNaBD9sDRgotdmA80hRoDxsXPBj0rtvekEsLPuLtOUdkvXhaz1-y1dvzcj5bZXsuq5Q1lpdWlE3FubEajDbCGqW0rBhWleSnAgEKpnOoQCgsN5YbZpUsRVEqJkfk4U-778PXaVCqWxcb9B46DIdYFzxXqtTFCbw_gwfT4qbe966F_qf-f0P-ArjLXfs</recordid><startdate>20031218</startdate><enddate>20031218</enddate><creator>Erchegyi, Judit</creator><creator>Waser, Beatrice</creator><creator>Schaer, Jean-Claude</creator><creator>Cescato, Renzo</creator><creator>Brazeau, Jean François</creator><creator>Rivier, Jean</creator><creator>Reubi, Jean Claude</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20031218</creationdate><title>Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling</title><author>Erchegyi, Judit ; Waser, Beatrice ; Schaer, Jean-Claude ; Cescato, Renzo ; Brazeau, Jean François ; Rivier, Jean ; Reubi, Jean Claude</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p139t-cf18f28c911bf6ab6b2fb556390e9931b6beaa7064a9a25e8df1b0f538278503</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Animals</topic><topic>Autoradiography</topic><topic>Binding, Competitive</topic><topic>Cell Line</topic><topic>Cricetinae</topic><topic>Cyclic AMP - biosynthesis</topic><topic>Humans</topic><topic>Iodine Radioisotopes</topic><topic>Isotope Labeling</topic><topic>Ligands</topic><topic>Membrane Proteins</topic><topic>Oligopeptides - chemical synthesis</topic><topic>Oligopeptides - chemistry</topic><topic>Oligopeptides - pharmacology</topic><topic>Peptides, Cyclic - chemical synthesis</topic><topic>Peptides, Cyclic - chemistry</topic><topic>Peptides, Cyclic - pharmacology</topic><topic>Radioligand Assay</topic><topic>Receptors, Somatostatin - agonists</topic><topic>Receptors, Somatostatin - chemistry</topic><topic>Somatostatin - analogs &amp; derivatives</topic><topic>Somatostatin - chemical synthesis</topic><topic>Somatostatin - chemistry</topic><topic>Somatostatin - pharmacology</topic><topic>Stereoisomerism</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Erchegyi, Judit</creatorcontrib><creatorcontrib>Waser, Beatrice</creatorcontrib><creatorcontrib>Schaer, Jean-Claude</creatorcontrib><creatorcontrib>Cescato, Renzo</creatorcontrib><creatorcontrib>Brazeau, Jean François</creatorcontrib><creatorcontrib>Rivier, Jean</creatorcontrib><creatorcontrib>Reubi, Jean Claude</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Erchegyi, Judit</au><au>Waser, Beatrice</au><au>Schaer, Jean-Claude</au><au>Cescato, Renzo</au><au>Brazeau, Jean François</au><au>Rivier, Jean</au><au>Reubi, Jean Claude</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J Med Chem</addtitle><date>2003-12-18</date><risdate>2003</risdate><volume>46</volume><issue>26</issue><spage>5597</spage><epage>5605</epage><pages>5597-5605</pages><issn>0022-2623</issn><abstract>After our discovery that H-c[Cys-Phe-Phe-DNal-Lys-Thr-Phe-Cys]-OH (ODN-8) had high affinity and marginal selectivity for human sst(3) (part 2 of this series: Erchegyi et al. J. Med. Chem., preceding paper in this issue)(11) and that H-c[Cys-Phe-Phe-DTrp-Lys-Thr-Phe-Cys]-OH (ODT-8, 3) had high affinity and marginal selectivity for human sst(4), that H-c[Cys-Phe-Tyr-D-threo-beta-Me2Nal-Lys-Thr-Phe-Cys]-OH had high affinity for all sst's except for sst(1), and that H-c[Cys-Phe-Tyr-L-threo-beta-Me2Nal-Lys-Thr-Phe-Cys]-OH had high affinity for sst(4) (IC(50) = 2.1 nM), with more than 50-fold selectivity toward the other receptors (parts 1 and 2 of this series: Rivier et al. and Erchegyi et al. J. Med. Chem., preceding papers in this issue), we found H-c[Cys-Phe-Phe-Trp-Lys-Thr-Phe-Cys]-OH (OLT-8, 2), H-c[Cys-Phe-Phe-L-threo-beta-MeTrp-Lys-Thr-Phe-Cys]-OH (4) and H-c[Cys-Phe-Phe-D-threo-beta-MeTrp-Lys-Thr-Phe-Cys]-OH (5) to have very high affinity for sst(4) (IC(50) = 0.7, 1.8, and 4.0 nM, respectively) and 5- to 10-fold selectivity versus the other sst's. From earlier work, we concluded that an l-amino acid at position 8 and a tyrosine or 4-aminophenylalanine substitution at position 7 may lead to high sst(4) selectivity. In fact, [Tyr(7)]-2 (6) and [Tyr(7)]-3 (7) show ca. 5-fold selectivity for sst(4), and [Aph(7)]-2 (8) and [Aph(7)]-3 (9) have high sst(4) affinity (IC(50) = 1.2 and 0.88 nM, respectively) and selectivity, suggesting that indeed an l-residue at position 8 will direct selectivity toward sst(4). Unexpectedly, [Ala(7)]-2 (10) and [Ala(7)]-3 (11) have very high sst(4) affinity (IC(50) = 0.84 and 0.98 nM, respectively) and selectivity (&gt;600- and 200-fold, respectively). The combination of Tyr(2) and dTrp(8) in analogues 14 and 22 did not affect the affinity of the analogues for sst(4) (IC(50) = 1.2 and 1.1 nM, respectively) but resulted in loss of selectivity, whereas the combination of Tyr(2) and LTrp(8) in H-Tyr-c[Cys-Phe-Aph-Trp-Lys-Thr-Phe-Cys]-OH (13) and H-Tyr-c[Cys-Phe-Ala-Trp-Lys-Thr-Phe-Cys]-OH(19) retained high affinity (IC(50) = 1.9 and 1.98 nM, respectively) and sst(4) selectivity (&gt;50 and &gt;250, respectively). Interestingly, the same substitutions at positions 2 and 7, with l-threo-beta-MeTrp at position 8, yielded a much less selective analogue (20). Carbamoylation of the N-terminus of most of these analogues resulted in slightly improved affinity, selectivity, or both. Other amino acid substitutions in this series, such as those with Amp (25, 26), Orn (27), or IAmp (29) at position 7, were also tolerated but with a 2- to 3-fold loss of affinity and concomitant loss of selectivity. Analogous peptides with a tyrosine at position 11 (31-36) were less selective than the corresponding peptides with a tyrosine at position 2. Several analogues in this series compared favorably with the non-peptide L-803,087 (37) in terms of affinity and selectivity. Analogues 8, 10, and 21 potently inhibited the forskolin-stimulated cAMP production in sst(4)-transfected cells, therefore acting as full agonists. Cold monoiodination of 19 yielded 21, with retention of high sst(4) selectivity and affinity (IC(50) = 3.5 nM). (125)Iodinated 19 selectively binds to sst(4)-transfected cells but not to sst(1-3)- or sst(5)-transfected cells. Binding in sst(4)-transfected cells was completely displaced by SRIF-28 or the sst(4)-selective L-803,087.</abstract><cop>United States</cop><pmid>14667214</pmid><doi>10.1021/jm030245x</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2003-12, Vol.46 (26), p.5597-5605
issn 0022-2623
language eng
recordid cdi_proquest_miscellaneous_71455867
source MEDLINE; American Chemical Society Journals
subjects Animals
Autoradiography
Binding, Competitive
Cell Line
Cricetinae
Cyclic AMP - biosynthesis
Humans
Iodine Radioisotopes
Isotope Labeling
Ligands
Membrane Proteins
Oligopeptides - chemical synthesis
Oligopeptides - chemistry
Oligopeptides - pharmacology
Peptides, Cyclic - chemical synthesis
Peptides, Cyclic - chemistry
Peptides, Cyclic - pharmacology
Radioligand Assay
Receptors, Somatostatin - agonists
Receptors, Somatostatin - chemistry
Somatostatin - analogs & derivatives
Somatostatin - chemical synthesis
Somatostatin - chemistry
Somatostatin - pharmacology
Stereoisomerism
Structure-Activity Relationship
title Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T18%3A12%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novel%20sst(4)-selective%20somatostatin%20(SRIF)%20agonists.%203.%20Analogues%20amenable%20to%20radiolabeling&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Erchegyi,%20Judit&rft.date=2003-12-18&rft.volume=46&rft.issue=26&rft.spage=5597&rft.epage=5605&rft.pages=5597-5605&rft.issn=0022-2623&rft_id=info:doi/10.1021/jm030245x&rft_dat=%3Cproquest_pubme%3E71455867%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71455867&rft_id=info:pmid/14667214&rfr_iscdi=true